These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36906159)

  • 1. TMT quantitative proteomics and network pharmacology reveal the mechanism by which asiaticoside regulates the JAK2/STAT3 signaling pathway to inhibit peritoneal fibrosis.
    Sun J; Tang L; Shan Y; Yu M; Sheng L; Huang L; Cao H; Dai H; Wang F; Zhao J; Sheng M
    J Ethnopharmacol; 2023 Jun; 309():116343. PubMed ID: 36906159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network pharmacology, molecular docking and experimental verification of the mechanism of huangqi-jixuecao herb pair in treatment of peritoneal fibrosis.
    Dai H; Shan Y; Yu M; Wang F; Zhou Z; Sun J; Sheng L; Huang L; Sheng M
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116874. PubMed ID: 37437794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition and oxidative stress via the Nrf2/HO-1 signaling pathway in the human peritoneal mesothelial cell line HMrSV5.
    Zhao J; Shi J; Shan Y; Yu M; Zhu X; Zhu Y; Liu L; Sheng M
    Cell Mol Biol Lett; 2020; 25():33. PubMed ID: 32514269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-methylpiperazine-diepoxyovatodiolide ameliorates peritoneal fibrosis via suppressing TGF-β/Smad and JAK/STAT signaling pathway.
    Mo M; Zeng Y; Zeng Y; Li S; He X; Chen X; Luo Q; Liu M; Luo C; Dou X; Peng F; Long H
    Chem Biol Interact; 2023 Sep; 382():110589. PubMed ID: 37268199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA AK089579 inhibits epithelial-to-mesenchymal transition of peritoneal mesothelial cells by competitively binding to microRNA-296-3p via DOK2 in peritoneal fibrosis.
    Zhang XW; Wang L; Ding H
    FASEB J; 2019 Apr; 33(4):5112-5125. PubMed ID: 30652956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-β1/Smad3 signaling pathway.
    Jiang N; Zhang Z; Shao X; Jing R; Wang C; Fang W; Mou S; Ni Z
    J Cell Physiol; 2020 Jan; 235(1):364-379. PubMed ID: 31236971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of Danshenol C in reversing peritoneal fibrosis: novel network pharmacological analysis and biological validation.
    Liang J; Cheng L; Feng J; Han Z; Huang C; Xie F; Li Y; Luo X; Wang Q; He J; Chen H
    BMC Complement Med Ther; 2023 Oct; 23(1):361. PubMed ID: 37833759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of STAT3 Signaling in High Glucose-Induced Epithelial Mesenchymal Transition in Human Peritoneal Mesothelial Cell Line HMrSV5.
    Zhang P; Dai H; Peng L
    Kidney Blood Press Res; 2019; 44(2):179-187. PubMed ID: 30943519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and identification of the components in Cybister chinensis Motschulsky against inflammation and their mechanisms of action based on network pharmacology and molecular docking.
    Che YH; Xu ZR; Ni LL; Dong XX; Yang ZZ; Yang ZB
    J Ethnopharmacol; 2022 Mar; 285():114851. PubMed ID: 34808299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin suppresses epithelial-to-mesenchymal transition of peritoneal mesothelial cells (HMrSV5) through regulation of transforming growth factor-activated kinase 1 (TAK1).
    Zhao JL; Guo MZ; Zhu JJ; Zhang T; Min DY
    Cell Mol Biol Lett; 2019; 24():32. PubMed ID: 31143210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parthenolide alleviates peritoneal fibrosis by inhibiting inflammation via the NF-κB/ TGF-β/Smad signaling axis.
    Zhang Y; Feng W; Peng X; Zhu L; Wang Z; Shen H; Chen C; Xiao L; Li S; Zhao Y; Lin M; Huang Y; Long H; Liang J
    Lab Invest; 2022 Dec; 102(12):1346-1354. PubMed ID: 36307537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveolin1 and YAP drive mechanically induced mesothelial to mesenchymal transition and fibrosis.
    Strippoli R; Sandoval P; Moreno-Vicente R; Rossi L; Battistelli C; Terri M; Pascual-Antón L; Loureiro M; Matteini F; Calvo E; Jiménez-Heffernan JA; Gómez MJ; Jiménez-Jiménez V; Sánchez-Cabo F; Vázquez J; Tripodi M; López-Cabrera M; Del Pozo MÁ
    Cell Death Dis; 2020 Aug; 11(8):647. PubMed ID: 32811813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centella triterpenes cream as a potential drug for the treatment of hypertrophic scar through inhibiting the phosphorylation of STAT3: A network pharmacology analysis and in vitro experiments.
    Tan M; Wu D; Zhou Y; Duan B
    J Cosmet Dermatol; 2023 Dec; 22(12):3511-3519. PubMed ID: 37563868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trehalose ameliorates peritoneal fibrosis by promoting Snail degradation and inhibiting mesothelial-to-mesenchymal transition in mesothelial cells.
    Miyake T; Sakai N; Tamai A; Sato K; Kamikawa Y; Miyagawa T; Ogura H; Yamamura Y; Oshima M; Nakagawa S; Sagara A; Shinozaki Y; Toyama T; Kitajima S; Hara A; Iwata Y; Shimizu M; Furuichi K; Kaneko S; Wada T
    Sci Rep; 2020 Aug; 10(1):14292. PubMed ID: 32868830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network pharmacology and experimental verification to decode the action of Qing Fei Hua Xian Decotion against pulmonary fibrosis.
    Ke HL; Li RJ; Yu CC; Wang XP; Wu CY; Zhang YW
    PLoS One; 2024; 19(6):e0305903. PubMed ID: 38913698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Astragaloside IV Against the TGF-β1-Induced Epithelial-to-Mesenchymal Transition in Peritoneal Mesothelial Cells by Promoting Smad 7 Expression.
    Zhang L; Li Z; He W; Xu L; Wang J; Shi J; Sheng M
    Cell Physiol Biochem; 2015; 37(1):43-54. PubMed ID: 26278416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin inhibits mesothelial-mesenchymal transition and alleviates postoperative peritoneal adhesions by blocking the TGF-β1/PI3K/AKT pathway.
    Li G; Ren Y; Li E; Deng K; Qu C; Zhang J; Zhang L; Wang X; Lian J; Zhou H; Wang Z; Shen T; Li X; Jiang Z
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117242. PubMed ID: 37777024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
    Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
    J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the Active Ingredients and Mechanism of Hudi Enteric-Coated Capsules in DSS-Induced Ulcerative Colitis Mice Based on Network Pharmacology and Experimental Verification.
    Ding P; Liu J; Li Q; Lu Q; Li J; Shi R; Shi L; Mao T; Ge D; Niu H; Peng G; Wang Z
    Drug Des Devel Ther; 2021; 15():4259-4273. PubMed ID: 34675488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and significance of SIRT6 in human peritoneal dialysis effluents and peritoneal mesothelial cells.
    Shi SS; Zhang YQ; Zhang LQ; Li YF; Zhou XS; Li RS
    Int Urol Nephrol; 2024 Mar; ():. PubMed ID: 38483736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.